Leuthold Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,208
Closed -$481K 215
2021
Q4
$481K Sell
2,208
-25
-1% -$5.24K 0.06% 144
2021
Q3
$423K Hold
2,233
0.05% 143
2021
Q2
$394K Sell
2,233
-61
-3% -$10.5K 0.05% 144
2021
Q1
$376K Sell
2,294
-57
-2% -$8.72K 0.05% 144
2020
Q4
$327K Sell
2,351
-24,165
-91% -$3.05M 0.04% 149
2020
Q3
$2.96M Sell
26,516
-284
-1% -$32.8K 0.41% 86
2020
Q2
$2.49M Buy
+26,800
New +$2.28M 0.37% 93
2019
Q4
Sell
-7,188
Closed -$604K 192
2019
Q3
$604K Sell
7,188
-369
-5% -$27.9K 0.08% 119
2019
Q2
$494K Sell
7,557
-1,364
-15% -$78.6K 0.06% 138
2019
Q1
$526K Sell
8,921
-505
-5% -$30.2K 0.07% 138
2018
Q4
$499K Buy
+9,426
New +$517K 0.07% 139

Other funds holding MEDP

Leuthold Group's MEDP Position: Q1 2022 in Review

Leuthold Group sold out of Medpace (MEDP) in Q1 2022, closing a stake of 2,208 shares — an estimated $481K sold.

Leuthold Group first reported a position in MEDP in Q4 2018 and held it in 11 quarters. The position peaked at $2.96M in Q3 2020. 349 funds tracked by Wall St. Rank hold MEDP as of Q1 2022.

  • Leuthold Group reported no remaining Medpace position as of Q1 2022 after selling out during the quarter.
  • Leuthold Group sold 2,208 Medpace shares in Q1 2022, an estimated $481K.
  • Leuthold Group first reported a position in Medpace in Q4 2018 and held it in 11 quarters.
  • Leuthold Group's Medpace position peaked at $2.96M in Q3 2020.
  • 349 funds tracked by Wall St. Rank held Medpace as of Q1 2022.

Based on Leuthold Group's 13F filing for Q1 2022, filed 4 May 2022.